245 Summer Street,
Boston , MA, 02210
Boston , MA, 02210
Summary
The fund seeks capital appreciation by investing in companies in the United States.
The investment process is designed to highlight companies that are engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine.
Next, the research team evaluates a company’s financial condition and industry position, as well as market and economic conditions.
Then More
Link
Directors
Oct 13, 2023- OSCAR MUNOZ
- ROBERT A LAWRENCE
- THOMAS A KENNEDY
- BETTINA DOULTON
- VICKI L FULLER
- THOMAS P BOSTICK
- PATRICIA L KAMPLING
- DENNIS J DIRKS
- DONALD F DONAHUE
- MICHAEL E WILEY
- SUSAN TOMASKY
- DAVID M THOMAS
- VIJAY ADVANI
Chief Compliance Officer
- JASON POGORELEC
Fund Manager(s)
Price
- 52-Week High/Low
- $68.86 - $52.22
- Turnover
- 33%
- Expense Ratio
- 0.94%
Company Name |
Holding |
| BOSTON SCIENTIFIC CORP | 9.49 % |
| ELI LILLY and CO | 8.23 % |
| UNITEDHEALTH GROUP INC | 7.8 % |
| DANAHER CORP | 6.37 % |
| REGENERON PHARMACEUTICALS INC | 4.36 % |
| Fidelity Revere Street Trust | 4.19 % |
| MERCK and CO INC | 3.92 % |
| CIGNA GROUP (THE) | 3.43 % |
| PENUMBRA INC | 3.04 % |
| STRYKER CORP | 2.34 % |
| More | 2.34 % |
Documents
Performance
YTD
1.5%
3 Year
-8.7%
5 Year
32.56%
Best
55.75%
2013
Worst
-33.01%
2008
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 6.6% | 0.5% | -8.8% | 1.4% | -11.1% | 10.4% | 5.2% | 12.2% | -11.7% | 11.8% |
| Q2 | -5.7% | 2.5% | -12.2% | 6.9% | 20.5% | 1.8% | 10% | 7.9% | 5.7% | 1.4% |
| Q3 | - | -6.9% | 2.4% | -7.4% | -2.1% | -6.7% | 10.7% | 3.7% | 4.7% | -19.5% |
| Q4 | - | 9% | 6.1% | 4% | 9% | 20.9% | -14.9% | -2.1% | -8.3% | 9% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 0.5% | 4.8% | 1.2% | -6.6% | - | - | - | - | - | - | - | - |
| 2023 | 2.6% | -4.1% | 2.2% | 3.2% | -3.2% | 2.5% | 0.3% | -2.9% | -4.5% | -5.1% | 4.8% | 8.9% |
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2% | 4% | -13% | 5% | 14% | 0% | 7% | 24% | -10% | -1% |
Alpha
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| FACDX | 2% | 4% | -13% | 5% | 14% | - | 7% | 24% | -10% | -1% |
| S&P 500 | - | - | -21% | 27% | 16% | 29% | -6% | 19% | 10% | -1% |
| Alpha | 2% | 4% | 8% | -22% | -2% | - | 13% | 5% | -20% | 0% |